Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D000224:Addison Disease / Q000188:drug therapy / Q000378:metabolism; D000311:Adrenal Glands / Q000473:pathology; D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D000616:Aminoglutethimide / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000652:urine; D003907:Dexamethasone; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008297:Male; D009362:Neoplasm Metastasis; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011728:Pyridones / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use*; D012636:Secretory Rate
D015065:17-Hydroxycorticosteroids; D000814:Aniline Compounds; D000927:Anticonvulsants; D011728:Pyridones; D000616:Aminoglutethimide; D000450:Aldosterone; D003907:Dexamethasone; D012110:Reserpine; D006854:Hydrocortisone